SCHEMBL2963375

SCHEMBL2963375

CC(C)(C)c1ccc(N)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
GAA P10253 2/20 0.52
RECQL P46063 2/20 0.52
MAPT P10636 2/20 0.52
MEN1 O00255 1/20 0.52
PKM P14618 1/20 0.52
KMT2A Q03164 1/20 0.52
TSHR P16473 6/20 0.50
CYP3A4 P08684 4/20 0.50
MAPK1 P28482 2/20 0.48
HSD17B2 P37059 2/20 0.42
CYP2C19 P33261 1/20 0.42
HPGD P15428 3/20 0.41
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ESR2 Q92731 1/20 0.41
THRB P10828 1/20 0.41
CASP1 P29466 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30279249 1.00 ALDH1A1 (0.52) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL2811051 0.86 TSHR (0.50) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL9612031 0.84 TSHR (0.48) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL22280536 0.84 CYP3A4 (0.48) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL14307623 0.83 TSHR (0.46) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL3790287 0.82 ALDH1A1 (0.57) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL4823779 0.79 NPC1 (0.44) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL22280537 0.79 ESR2 (0.50) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL11304152 0.79 TSHR (0.52) ALDH1A1GAARECQLMAPTMEN1
SCHEMBL256203 0.78 ALDH1A1 (0.64) ALDH1A1GAARECQLMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007523865-A 2007-08-23 JP claimed
US-7129235-B2 Amides useful for treating pain ABBOTT LABORATORIES (US) 2006-10-31 US claimed
EP-1646621-A2 NOVEL AZAHETEROCYCLIC AMIDES USEFUL FOR TREATING PAIN Abbott Laboratories (US) 2006-04-19 EP claimed
US-20050080095-A1 administering a therapeuitcally effective amount of 3'-(trifluoromethyl)-N-{4-[(trifluoromethyl)sulfonyl]phenyl}-3,6-dihydro-2H-1,2'-bipyridine-4-carboxamide; antagonists of vanilloid receptor subtype I ABBVIE INC. 2005-04-14 US claimed
WO-2005007642-A2 NOVEL AZAHETEROCYCLIC AMIDES USEFUL FOR TREATING PAIN ABBOTT LABORATORIES (US) 2005-01-27 WO claimed
CN-122010988-A Organic compound and application thereof 北京鼎材科技股份有限公司 2026-05-12 CN disclosed
WO-2025100475-A1 COMPOSITION FOR IMAGE RECORDING AND METHOD FOR PRODUCING SAME キヤノン株式会社 2025-05-15 WO disclosed
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 US disclosed
CN-118076581-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-24 CN disclosed
US-20230389423-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-11-30 US disclosed
US-20230389423-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-11-30 US disclosed
EP-4273151-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Lg Chem, Ltd. (KR) 2023-11-08 EP disclosed
US-5354869-A Fluorescent dyes RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) 1994-10-11 US disclosed
WO-1994015903-A1 3,3 DIPHENYL PROP-2-YL AMINO ACID DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 1994-07-21 WO disclosed
WO-1993021181-A1 AZACYCLIC COMPOUNDS MERCK SHARP & DOHME LIMITED (GB) 1993-10-28 WO disclosed
EP-0426717-A1 OPTICAL MEMORY. RIEDEL DE HAEN AG (DE) 1991-05-15 EP disclosed
WO-1990001480-A1 OPTICAL MEMORY RIEDEL-DE HAEN AKTIENGESELLSCHAFT (DE) 1990-02-22 WO disclosed
EP-0069065-B1 PROCESS FOR THE ALKYLATION OR ARALKYLATION OF AROMATIC AMINES CIBA-GEIGY AG (CH) 1985-02-13 EP disclosed
US-4436936-A ACID CATALYSTS CIBA-GEIGY CORPORATION (US) 1984-03-13 US disclosed
EP-0069065-A1 Process for the alkylation or aralkylation of aromatic amines CIBA-GEIGY AG (CH) 1983-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 ALDH1A1 1441/4885GAA 771/4885RECQL 2962/4885
US-20050080095-A1 administering a therapeuitcally effective amount of 3'-(trifluoromethyl)-N-{4-[(trifluoromethyl)sulfonyl]phenyl}-3,6-dihydro-2H-1,2'-bipyridine-4-carboxamide; antagonists of vanilloid receptor subtype I TRPV1, OPRL1, TRPV6 ALDH1A1 843/4885GAA 2594/4885RECQL 1598/4885
US-20230389423-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, VDAC2, KCNC1 ALDH1A1 525/4885GAA 3115/4885RECQL 1281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.